Comparison between Quess Corp IPO and Thyrocare Technologies IPO.
Quess Corp IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Thyrocare Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Quess Corp IPO is up to ₹400.00 Cr whereas the issue size of the Thyrocare Technologies IPO is up to ₹479.21 Cr. The final issue price of Quess Corp IPO is ₹317.00 per share and of Thyrocare Technologies IPO is ₹446.00 per share.
| Quess Corp IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹310.00 per share | ₹420.00 per share |
| Issue Price (Upper) | ₹317.00 per share | ₹446.00 per share |
| Issue Price (Final) | ₹317.00 per share | ₹446.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 45 shares | 33 shares |
| Fresh Issue Size | 1,26,18,297 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹400.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 1,07,44,708 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹479.21 Cr |
| Issue Size Total | 1,26,18,297 shares | 1,07,44,708 shares |
| Issue Size Total (Amount) | up to ₹400.00 Cr | up to ₹479.21 Cr |
Quess Corp IPO opens on Jun 29, 2016, while Thyrocare Technologies IPO opens on Apr 27, 2016. The closing date of Quess Corp IPO and Thyrocare Technologies IPO is Jul 01, 2016, and Apr 29, 2016, respectively.
| Quess Corp IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Jun 28, 2016 | Apr 26, 2016 |
| Issue Open | Jun 29, 2016 | Apr 27, 2016 |
| Issue Close | Jul 01, 2016 | Apr 29, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jul 12, 2016 | May 09, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Quess Corp IPO P/E ratio is , as compared to Thyrocare Technologies IPO P/E ratio of .
| Quess Corp IPO | Thyrocare Technologies IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.51 | 64.96 | ||||
| Promoter Shareholding (Post-Issue) | 63.96 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹3992.72 Cr. | ₹2396.07 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 24.28% | 17.37% |
In the Quess Corp IPO Retail Individual Investors (RII) are offered 12,61,829 shares while in Thyrocare Technologies IPO retail investors are offered 12,61,829 shares. Qualified Institutional Buyers (QIB) are offered 37,85,490 shares in Quess Corp IPO and 21,48,942 shares in Thyrocare Technologies IPO.
| Quess Corp IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 56,78,234 shares | 32,23,411 shares |
| Market Maker Reservation | ||
| QIB | 37,85,490 shares | 21,48,942 shares |
| NII | 18,92,744 shares | 16,11,707 shares |
| RII | 12,61,829 shares | 37,60,648 shares |
| Employee | ||
| Others | ||
| Total | 1,26,18,297 shares | 1,07,44,708 shares |
Quess Corp IPO subscribed 143.99x in total, whereas Thyrocare Technologies IPO subscribed 73.55x.
| Quess Corp IPO | Thyrocare Technologies IPO | |
|---|---|---|
| QIB (times) | 59.02x | 73.18x |
| NII (times) | 392.21x | 225.30x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 31.23x | 8.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 143.99x | 73.55x |
